Name: Pediatric Pharmacology and Drug Therapy, an Issue of Pediatric Clinics of North America (Volume 64-6) (The Clinics: Internal Medicine, Volume 64-6) (en Inglés)
Price: 205.61 PEN
Availability: InStock
Author: Jacob V. Aranda Md Phd Frcpc Faap
ISBN: 9780323552905

portada Pediatric Pharmacology and Drug Therapy, an Issue of Pediatric Clinics of North America (Volume 64-6) (The Clinics: Internal Medicine, Volume 64-6) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Jacob V. Aranda Md Phd Frcpc Faap

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323552905

N° edición

Pediatric Pharmacology and Drug Therapy, an Issue of Pediatric Clinics of North America (Volume 64-6) (The Clinics: Internal Medicine, Volume 64-6) (en Inglés)

Jacob V. Aranda Md Phd Frcpc Faap (Autor) · Elsevier · Tapa Dura

Libro Nuevo

S/ 205,61

S/ 411,22

Ahorras: S/ 205,61

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Martes 11 de Junio y el Miércoles 26 de Junio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Pediatric Pharmacology and Drug Therapy, an Issue of Pediatric Clinics of North America (Volume 64-6) (The Clinics: Internal Medicine, Volume 64-6) (en Inglés)"

Dr. Aranda is an top expert in the area of pharmacology in the pediatric population. His issue has knowledgeable authors presenting clinical reviews on a wide variety of topics, from "hot areas " of drug therapy to drug abuse in children as well as current areas of debate in neonatal drug therapy. Articles are devoted to the following topics: New and Current Drug Therapies For Asthma In Children; Psychopharmacology Of Bipolar Disorders in Children and Adolescents; Designer Drug Abuse in School Children; Dietary Supplements in Children; Anticoagulant Therapies in Children; New Antimicrobials for Gram-Positive Infections in Children; Probiotics in Newborns And Children; Anticonvulsant Therapies in Newborns and Children; Immunomodulator Drug Therapies in Inflammatory Bowel Diseases in Children; Non-Steroidal Anti-Inflammatory Drugs in Newborns and Children; Metformin Use in Pre-Diabetic Children and Adolescents; Problems in Drug Dosing of Obese Children; Inhaled Drugs and Systemic Steroids for Bronchopulmonary Dysplasia; Antifungal Drugs in Newborns and Children; Antiviral Drugs In Newborns and Children; and Development of Drug Therapies for Newborns and Children. Readers will come away with the latest clinical information to help inform them when diagnosing and prescribing for children.